Evidence for an association of high levels of endogenous Acetyl-Ser-Asp-Lys-Pro, a potent mediator of angiogenesis, with acute myeloid leukemia development

Leukemia and Lymphoma

Volumn 47, Issue 9, 2006, Pages 1915-1920

  Liu, Jian Miao ^a   Bignon, Jérôme ^a   Ilic, Vesna ^a   Briscoe, Cecilia ^b   Lallemand, Jean Yves ^a   Riches, Andrew ^b   Wdzieczak Bakala, Joanna ^a  

^a CNRS   (France)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

AcSDKP; Angiogenesis; Diagnostic; Leukemia

Indexed keywords

ANGIOGENIC FACTOR; SERASPENIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME IMMUNOASSAY; LEUKEMIA CELL LINE; LEUKEMOGENESIS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; TUMOR VASCULARIZATION;

ANIMALS; BONE MARROW; DISEASE PROGRESSION; GROWTH INHIBITORS; IMMUNOENZYME TECHNIQUES; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MICE; MICE, INBRED CBA; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; SPLEEN;

EID: 33750451989     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600688131     Document Type: Article

References (29)

1. Lenfant, M and Wdzieczak-Bakala, J and Guittet, E and Prome, J and Sotty, D and Frindel, E. (1989) Inhibitor of hematopoietic pluripotent stem cell proliferation: Purification and determination of its structure Proc Natl Acad Sci USA, 86, pp. 779-782.
2. Bonnet, D and Lemoine, F and Pontvert-Delucq, S and Baillou, C and Najman, A and Guigon, M. (1993) Direct and reversible inhibitory effect of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Seraspenide) on the growth of human CD34+ subpopulations in response to growth factors Blood, 82, pp. 3307-3314.
3. Liu, J and Lawrence, F and Kovacevic, M and Bignon, J and Papadimitriou, E and Lallemand, J and (2003) The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo Blood, 101, pp. 3014-3020.
4. Wang, D and Carretero, O and Yang, X and Rhaleb, N and Liu, Y and Liao, T and (2004) N-acetyl-seryl-aspartyl-lysyl-proline stimulates angiogenesis in vitro and in vivo Am J Physiol Heart Circ Physiol, 287, pp. H2099-H2105.
5. Waeckel, L and Bignon, J and Liu, J and Markovits, D and Ebrahimian, T and Vilar, J and (2006) The tetrapeptide AcSDKP induces post-ischemic neovascularization through monocyte chemoattractant protein-1 signaling Arterioscler Thromb Vasc Biol, 26, pp. 773-779.
6. Fromes, Y and Liu, J and Kovacevic, M and Bignon, J and Wdzieczak-Bakala, J. (2006) The tetrapeptide AcSDKP improves skin flap survival and accelerates wound healing Wound Rep Reg. in press
7. Carmeliet, P and Jain, R. (2000) Angiogenesis in cancer and other diseases Nature, 407, pp. 249-257.
8. Ribatti, D and Scavelli, C and Roccaro, A and Crivellato, E and Nico, B and Vacca, A. (2004) Hematopoietic cancer and angiogenesis Stem Cells Dev, 13, pp. 484-495.
9. De Raeve, H and Van Marck, E and Van Camp, B and Vanderkerken, K. (2004) Angiogenesis and the role of bone marrow endothelial cells in haematological malignancies Histol Histopathol, 19, pp. 935-950.
10. Hepburn, M and Doherty, I and Briscoe, C and Riches, A. (1987) Transplantation and morphological studies of primary and passaged murine radiation-induced myeloid leukaemias Leukaemia Res, 11, pp. 1001-1009.
11. Gaulier, A and Fourcade, C and Szekeres, G and Pulik, M. (1994) Bone marrow one step fixation-decalcification in Lowy FMA solution: An immunohistological and in situ hybridization study Pathol Res Pract, 190, pp. 1149-1161.
12. Hussong, J and Rodgers, G and Shami, P. (2000) Evidence of increased angiogenesis in patients with acute myeloid leukemia Blood, 95, pp. 309-313.
13. Aguayo, A and Kantarjian, H and Manshouri, T and Gidel, C and Estey, E and Thomas, D and (2000) Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes Blood, 96, pp. 2240-2245.
14. Huang, W and Wang, Q. (2001) Bone marrow endothelial cells secrete thymosin beta4 and AcSDKP Exp Hematol, 29, pp. 12-18.
15. Wdzieczak-Bakala, J and Grillon, C and Robinson, S and Riches, A and Carde, P and Lenfant, M. (1993) Catabolism of the tetrapeptide N-Ac-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of hematopoietic stem cell (CFU-S) proliferation, following in vitro incubation with hematopoietic tissues from normal and leukemic mice Bull Cancer, 80, pp. 391-396.
16. Podar, K and Anderson, K. (2005) The pathophysiologic role of VEGF in hematologic malignancies: Therapeutic implications Blood, 105, pp. 1383-1395.
17. Bieker, R and Padro, T and Kramer, J and Steins, M and Kessler, T and Retzlaff, S and (2003) Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia Cancer Res, 63, pp. 7241-7246.
18. Santos, S and Dias, S. (2004) Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways Blood, 103, pp. 3883-3889.
19. Fiedler, W and Graeven, U and Ergun, S and Verago, S and Kilic, N and Stockschlader, M and (1997) Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia Blood, 89, pp. 1870-1875.
20. Boutonnat, J and Faussat, A and Marie, J and Bignon, J and Wdzieczak-Bakala, J and Barbier, M and (2005) Usefulness of PKH fluorescent labelling to study leukemic cell proliferation with various cytostatic drugs or acetyl tetrapeptide - AcSDKP BMC Cancer, 5, pp. 120-134.
21. Bonnet, D and Cesaire, R and Lemoine, F and Aoudjhane, M and Najman, A and Guigon, M. (1992) The tetrapeptide AcSDKP, an inhibitor of the cell-cycle status for normal human hematopoietic progenitors, has no effect on leukemic cells Exp Hematol, 20, pp. 251-255.
22. Cashman, J and Eaves, A and Eaves, C. (1994) The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: Evidence for an indirect mechanism Blood, 84, pp. 1534-1542.
23. Liozon, E and Pradelles, P and Venot, J and Rigaud, M and Cransac, M and Bordessoule, D and (1993) Serum levels of a negative regulator of cell proliferation (AcSDKP) are increased in certain human haemopathies Leukemia, 7, pp. 808-812.
24. Cha, H and Jeong, M and Kleinman, H. (2003) Role of thymosin beta 4 in tumor metastasis and angiogenesis J Natl Cancer Inst, 95, pp. 1674-1680.
25. Shimamura, R and Kudo, J and Kondo, H and Dohmen, K and Gondo, H and Okamura, S and (1990) Expression of the thymosin beta 4 gene during differentiation of hematopoietic cells Blood, 76, pp. 977-984.
26. Lenfant, M and Grillon, C and Rieger, K and Sotty, D and Wdzieczak-Bakala, J. (1991) Formation of acetyl-Ser-Asp-Lys-Pro, a new regulator of the hematopoietic system, through enzymatic processing of thymosin beta 4 Ann NY Acad Sci, 628, pp. 115-125.
27. Cavasin, M and Rhaleb, N and Yang, X and Carretero, O. (2004) Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP Hypertension, 43, pp. 1140-1145.
28. Perez-Atayde, A and Sallan, S and Tedrow, U and Connors, S and Allred, E and Folkman, J. (1997) Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia J Pathol, 150, pp. 815-821.
29. Vacca, A and Ria, R and Semeraro, F and Merchionne, F and Coluccia, M and Boccarelli, A and (2003) Endothelial cells in the bone marrow of patients with multiple myeloma Blood, 102, pp. 3340-3348.